GURUFOCUS.COM » STOCK LIST » Creative Antibiotics AB (OSTO:CAS) » Definitions » Accounts Receivable

Creative Antibiotics AB (OSTO:CAS) Accounts Receivable : kr0.00 Mil (As of Mar. 2013)


View and export this data going back to . Start your Free Trial

What is Creative Antibiotics AB Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Creative Antibiotics AB's accounts receivables for the quarter that ended in Mar. 2013 was kr0.00 Mil.

Accounts receivable can be measured by Days Sales Outstanding.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Creative Antibiotics AB's Net-Net Working Capital per share for the quarter that ended in Mar. 2013 was kr-0.04.


Creative Antibiotics AB Accounts Receivable Historical Data

The historical data trend for Creative Antibiotics AB's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creative Antibiotics AB Accounts Receivable Chart

Creative Antibiotics AB Annual Data
Trend Jun08 Jun09 Jun10 Dec11
Accounts Receivable
- - - -

Creative Antibiotics AB Quarterly Data
Jun08 Mar09 Jun09 Sep09 Dec09 Mar10 Sep10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Mar13
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Creative Antibiotics AB Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Creative Antibiotics AB Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Creative Antibiotics AB's Days Sales Outstanding for the quarter that ended in Mar. 2013 is calculated as:

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Creative Antibiotics AB's accounts receivable are only considered to be worth 75% of book value:

Creative Antibiotics AB's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2013 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(9.446+0.75 * 0+0.5 * 0-11.218
-0-0)/47.001
=-0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Creative Antibiotics AB Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Creative Antibiotics AB's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Creative Antibiotics AB (OSTO:CAS) Business Description

Traded in Other Exchanges
N/A
Address
Website

Creative Antibiotics AB (OSTO:CAS) Headlines

From GuruFocus

Cascade Acquisition Corp (CAS.U) CEO Jay N. Levine Bought $2.5 million of Shares

By GuruFocus Research GuruFocus Editor 11-27-2020

Cascade Acquisition Corp. Announces Liquidation

By GuruFocusNews GuruFocusNews 07-07-2022

Cascade Acquisition Corp. Announces Liquidation

By GlobeNewswire GlobeNewswire 05-18-2022

Cascade Acquisition Corp. Announces Liquidation

By GuruFocusNews GuruFocusNews 06-27-2022

Cascade Acquisition Corp. Announces Liquidation

By GuruFocusNews GuruFocusNews 05-18-2022

Cascade Acquisition Corp. Announces Liquidation

By GuruFocusNews GuruFocusNews 05-28-2022

Cascade Acquisition Corp. Announces Liquidation

By GuruFocusNews GuruFocusNews 06-07-2022